Junbo Ge Selected Research

Myocardial Infarction

11/2022	Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention.
10/2022	Aortic valve calcification predicts poor outcomes after primary percutaneous coronary intervention.
6/2022	Impact of intracoronary reteplase during primary percutaneous coronary intervention on infarct size in large anterior myocardial infarction: rationale and design of the RECOVER II trial.
3/2022	Device-based antegrade dissection re-entry versus parallel wire techniques for the percutaneous revascularization of coronary chronic total occlusions.
1/2022	A comparison of long-term clinical outcomes between percutaneous coronary intervention (PCI) and medical therapy in patients with chronic total occlusion in noninfarct-related artery after PCI of acute myocardial infarction.
1/2022	Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.
1/2022	β-Hydroxybutyrate Exacerbates Hypoxic Injury by Inhibiting HIF-1α-Dependent Glycolysis in Cardiomyocytes-Adding Fuel to the Fire?
1/2022	Cardiac Resident Macrophage-Derived Legumain Improves Cardiac Repair by Promoting Clearance and Degradation of Apoptotic Cardiomyocytes After Myocardial Infarction.
1/2022	Anatomic and Hemodynamic Plaque Characteristics for Subsequent Coronary Events.
1/2022	A randomized multicenter trial to evaluate early invasive strategy for patients with acute ST-segment elevation myocardial infarction presenting 24-48 hours from symptom onset: Protocol of the RESCUE-MI study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junbo Ge Research Topics

Disease

116	Myocardial Infarction 11/2022 - 01/2005
80	Heart Failure 12/2022 - 05/2006
57	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 02/2005
40	Thrombosis (Thrombus) 01/2023 - 08/2005
39	Atherosclerosis 03/2022 - 09/2004
34	Fibrosis (Cirrhosis) 06/2022 - 05/2011
32	Hemorrhage 01/2022 - 02/2010
31	Inflammation (Inflammations) 01/2023 - 12/2006
29	Cardiomegaly (Heart Hypertrophy) 01/2022 - 02/2008
28	Infarction (Infarctions) 06/2022 - 01/2004
27	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 02/2005
27	ST Elevation Myocardial Infarction 06/2022 - 05/2007
25	Hypoxia (Hypoxemia) 01/2022 - 02/2011
21	Ischemia 03/2022 - 04/2010
21	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2004
21	Acute Coronary Syndrome 01/2022 - 06/2009
17	Hypertension (High Blood Pressure) 05/2022 - 12/2010
17	Stroke (Strokes) 01/2022 - 08/2005
17	Death (Near-Death Experience) 01/2022 - 01/2010
16	Reperfusion Injury 01/2022 - 06/2012
16	Coronary Disease (Coronary Heart Disease) 01/2022 - 06/2009
15	Atrial Fibrillation 06/2022 - 02/2002
15	Hypertrophy 01/2022 - 05/2011
13	Heart Diseases (Heart Disease) 01/2022 - 01/2013
13	Pathologic Constriction (Stenosis) 01/2021 - 02/2007
12	Myocarditis (Carditis) 01/2022 - 04/2008
11	Infections 01/2022 - 07/2003
11	Cardiomyopathies (Cardiomyopathy) 01/2022 - 05/2011
10	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2022 - 05/2006
9	Ventricular Remodeling 01/2022 - 07/2005
8	Type 2 Diabetes Mellitus (MODY) 12/2022 - 11/2017
8	Atherosclerotic Plaque (Atheroma) 01/2022 - 11/2004
7	Aortic Valve Insufficiency (Aortic Regurgitation) 06/2022 - 11/2012
7	Diabetes Mellitus 01/2022 - 01/2010
7	Necrosis 01/2022 - 01/2010
6	Hyperplasia 01/2023 - 12/2006
6	Rupture 01/2022 - 06/2011
5	Ischemic Stroke 11/2022 - 04/2015
5	Pathologic Processes 06/2022 - 01/2014
5	Hyperlipidemias (Hyperlipidemia) 01/2020 - 11/2004

Drug/Important Bio-Agent (IBA)

25	omega-Chloroacetophenone (Mace)IBA 03/2022 - 02/2005
21	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2006
17	oxidized low density lipoproteinIBA 01/2022 - 12/2004
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
13	Angiotensin IIIBA 01/2022 - 02/2008
12	Pharmaceutical PreparationsIBA 06/2022 - 09/2012
12	CytokinesIBA 05/2022 - 10/2012
12	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 07/2009
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2021 - 04/2010
11	Sirolimus (Rapamycin)FDA Link 01/2023 - 05/2007
11	LipidsIBA 11/2022 - 11/2004
11	Therapeutic UsesIBA 01/2022 - 01/2004
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2004
10	Apolipoproteins E (ApoE)IBA 01/2022 - 11/2012
9	Messenger RNA (mRNA)IBA 06/2022 - 05/2006
9	Aldehyde DehydrogenaseIBA 01/2022 - 01/2013
9	CollagenIBA 01/2022 - 11/2006
9	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 07/2009
8	Troponin T (Troponin T1)IBA 06/2022 - 01/2010
8	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 08/2015
8	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 05/2013
7	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 12/2018
7	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2012
7	salicylhydroxamic acid (SHAM)IBA 01/2020 - 11/2012
7	PolymersIBA 01/2020 - 06/2012
7	Phenobarbital (Luminal)FDA Link 12/2019 - 02/2005
6	Circular RNAIBA 06/2022 - 01/2020
6	Clopidogrel (Plavix)FDA Link 01/2022 - 09/2010
6	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 12/2004
6	CholesterolIBA 01/2021 - 11/2004
6	LDL CholesterolIBA 01/2021 - 05/2010
6	Mitochondrial Aldehyde DehydrogenaseIBA 01/2021 - 09/2014
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 02/2010
6	Valsartan (Vals)FDA Link 01/2020 - 12/2010
6	qiliqiangxinIBA 01/2020 - 03/2012
6	Type 1 Angiotensin ReceptorIBA 08/2015 - 06/2010
5	HMGB1 Protein (HMG1)IBA 01/2022 - 03/2016
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
5	InflammasomesIBA 12/2021 - 01/2017
5	Everolimus FDA Link 11/2021 - 02/2011
5	paragonIBA 01/2021 - 01/2017
5	TicagrelorIBA 01/2021 - 10/2014
5	evolocumabIBA 01/2021 - 09/2018
5	EnzymesIBA 01/2021 - 11/2010
5	MetalsIBA 01/2021 - 02/2005
5	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020 - 01/2017
5	Atorvastatin (Lipitor)FDA Link 01/2019 - 10/2011

Therapy/Procedure

61	Percutaneous Coronary Intervention 10/2022 - 05/2007
59	Therapeutics 12/2022 - 01/2004
48	Stents 01/2023 - 02/2005
16	Transplantation 07/2021 - 01/2004
14	Drug-Eluting Stents 01/2022 - 01/2010
12	Ligation 01/2021 - 07/2005
11	Cardiac Resynchronization Therapy 01/2022 - 10/2011
8	Catheters 06/2022 - 06/2002
7	Denervation 01/2021 - 01/2014
6	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 04/2008
5	Transcatheter Aortic Valve Replacement 06/2022 - 04/2012
5	Patient Readmission 01/2021 - 10/2011
5	Secondary Prevention 11/2019 - 01/2012